$HTFL insider trading
Over the last 12 months, Heartflow insiders reported 1 buy totaling $1.1M and 21 sales totaling $131.0M across SEC Form 4 filings. 86% of those filings were made under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- $1.1M 1 event
- Sold · 12m
- $131.0M 21 events
- Events · 12m
- 22 Form 4 filings, grouped
- Insiders · 12m
- 6 distinct reporters
- 10b5-1 share
- 86% of events, not dollars
All insider trades
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | Verghese VikramChief Financial Officer · O | ▼ Sale | 33,416 | $49.85 | $1.7M | -13.1% | plan · 2 tranches |
| Aug 21, 2026 | Farquhar John C.M.Chief Executive Officer · O·D | ▼ Sale | 27,230 | $50 | $1.4M | -7% | plan |
| Aug 18, 2026 | Farquhar John C.M.Chief Executive Officer · O·D | ▼ Sale | 32,676 | $45 | $1.5M | -7.8% | plan |
| Aug 17, 2026 | Rogers CampbellChief Medical Officer · O | ▼ Sale | 9,219 | $41.23 | $380K | -9.6% | plan |
| Aug 14, 2026 | Farquhar John C.M.Chief Executive Officer · O·D | ▼ Sale | 15,560 | $39.06 | $608K | -3.6% | plan |
| Aug 10, 2026 | Farquhar John C.M.Chief Executive Officer · O·D | ▼ Sale | 22,562 | $28.31 | $639K | -4.9% | plan |
| Jul 15, 2026 | Rogers CampbellChief Medical Officer · O | ▼ Sale | 9,219 | $25.72 | $237K | -9.4% | plan |
| Jul 10, 2026 | Farquhar John C.M.Chief Executive Officer · O·D | ▼ Sale | 22,562 | $27.75 | $626K | -4.9% | plan |
| Jun 24, 2026 | Farquhar John C.M.Chief Executive Officer · O·D | ▼ Sale | 38,900 | $35 | $1.4M | -7.8% | plan |
| Jun 10, 2026 | Farquhar John C.M.Chief Executive Officer · O·D | ▼ Sale | 22,562 | $28.5 | $643K | -4.3% | plan |
| Apr 30, 2026 | Bain Capital Life Sciences Investors, LLC10% | ▼ Sale | 2,000,000 | $29.45 | $58.9M | -19.1% | 4 tranches · indirect |
| Apr 10, 2026 | Farquhar John C.M.Chief Executive Officer · O·D | ▼ Sale | 22,562 | $26.72 | $603K | -3.9% | plan |
| Apr 1, 2026 | Rogers CampbellChief Medical Officer · O | ▼ Sale | 64,533 | $24.64 | $1.6M | -44.3% | plan |
| Mar 19, 2026 | Rogers CampbellChief Medical Officer · O | ▼ Sale | 64,533 | $25.69 | $1.7M | -45.1% | plan |
| Mar 18, 2026 | Farquhar John C.M.Chief Executive Officer · O·D | ▼ Sale | 9,725 | $25 | $243K | -1.7% | plan |
| Mar 10, 2026 | Farquhar John C.M.Chief Executive Officer · O·D | ▼ Sale | 12,837 | $22.66 | $291K | -2.2% | plan |
| Mar 5, 2026 | Cullivan Julie AD | ▼ Sale | 9,122 | $25 | $228K | -25.1% | plan |
| Feb 12, 2026 | Rogers CampbellChief Medical Officer · O | ▼ Sale | 65,153 | $24.49 | $1.6M | -46.1% | plan |
| Feb 10, 2026 | Farquhar John C.M.Chief Executive Officer · O·D | ▼ Sale | 22,562 | $27.46 | $620K | -3.7% | plan |
| Feb 5, 2026 | Cullivan Julie AD | ▼ Sale | 8,000 | $27.32 | $219K | -18% | plan |
| Feb 4, 2026 | Bain Capital Life Sciences Investors, LLC10% | ▼ Sale | 2,000,000 | $28.05 | $56.1M | -16.1% | indirect |
| Dec 16, 2025 | Lightcap Jeffrey CD | ▲ Buy | 40,000 | $26.34 | $1.1M | — | — |
Every $HTFL filing on this page is one API call away
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Heartflow filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $HTFL feed.